Lipids and Cerebrovascular Disease: Research and Practice
Open accessAbstract
partly because of differential use of both fasting and nonfasting levels (Table 1).5,11,12 In Lipids and Cerebrovascular Disease
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In individuals with T2DM, lipid abnormalities are vital contributors to the risk of ASCVD, including ischemic stroke.
“In individuals with T2DM, lipid abnormalities are vital contributors to the risk of ASCVD, including the risk of ischemic stroke [35].”
From Protection against stroke with glucagon-like peptide-1 receptor agonists: a comprehensive review of potential mechanisms (2022) · cites this paper as [35]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
The citation lists haven’t been fetched yet
References 65 · Cited by 176
- Authors
- Yaghi, S., & Elkind, M. S. V.
- Affiliations
- Brown University (US)
- Venue
- Stroke
- Published
- 2015-11
- Volume
- 46
- Issue
- 11
- Pages
- 3322-3328
- ISSN
- 0039-2499 (ISSN-L)
- 1524-4628
- PMC
- PMC4624572
- OpenAlex
- W2226142946
- Cited by
- 176
- References
- 65
- Citations by year
- 2026: 15 · 2025: 24 · 2024: 20 · 2023: 27 · 2022: 22 · 2021: 20 · 2020: 20 · 2019: 16 · 2018: 4 · 2017: 7 · 2016: 1
- FWCI
- 4.03
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Stroke (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of Neurological Disorders and Stroke (P50NS049060, U10NS086728)
- Topics
- Health Sciences › Medicine › Surgery › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Epidemiology › Acute Ischemic Stroke Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- lipids, cerebrovascular disease
- MeSH terms
- Ezetimibe, Hypolipidemic Agents, Cerebral Hemorrhage, Brain Ischemia, Humans, Cholesterol, HDL, Cholesterol, LDL, Primary Prevention, Triglycerides, Lipoprotein(a), Practice Guidelines as Topic, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Stroke, Dyslipidemias, Secondary Prevention, Leukoencephalopathies, Fibric Acids
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
